Shopping Cart

Dompe Farmaceutici SpA-Pharmaceuticals & Healthcare-Deals and Alliances Profile

SKU
GDPH182029D
READ MORE
USD 250
Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750
Dompe Farmaceutici SpA (Dompe) is a biopharmaceutical company that concentrates on the development of novel therapies for the treatment of rare and orphan diseases. The company's product pipeline include C5aR Antagonists, TRPM8 Blockers pain, TRPM8 Blockers urology, BKB1R Antagonists, CNR2 Agonists and GPR120 Agonists. It provides treatment in the therapeutic areas of respiratory diseases, chronic obstructive pulmonary disease, pulmonary arterial hypertension, cystic fibrosis, osteoarticular solutions, pain therapy and dentistry. Dompe's target research areas include respiratory diseases, oncology, diabetology, ophthalmology, organ transplantation, chronic obstructive pulmonary disease and pulmonary arterial hypertension among others. The company has operations in the US and Albania. Dompe is headquartered in Milan, Italy.
READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Summary

Dompe Farmaceutici SpA (Dompe) is a biopharmaceutical company that concentrates on the development of novel therapies for the treatment of rare and orphan diseases. The company's product pipeline include C5aR Antagonists, TRPM8 Blockers pain, TRPM8 Blockers urology, BKB1R Antagonists, CNR2 Agonists and GPR120 Agonists. It provides treatment in the therapeutic areas of respiratory diseases, chronic obstructive pulmonary disease, pulmonary arterial hypertension, cystic fibrosis, osteoarticular solutions, pain therapy and dentistry. Dompe's target research areas include respiratory diseases, oncology, diabetology, ophthalmology, organ transplantation, chronic obstructive pulmonary disease and pulmonary arterial hypertension among others. The company has operations in the US and Albania. Dompe is headquartered in Milan, Italy.

Dompe Farmaceutici SpA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Advanced Accelerator Secures USD57 Million In Venture Financing 10

Partnerships 11

Lubris Biopharma Enters into Agreement with Dompe Farmaceutici 11

Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 11

Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 12

Licensing Agreements 13

Scil Proteins Enters Into Licensing Agreement With Anabasis 13

Dompe Enters Into Licensing Agreement With Anabasis 14

Asset Transactions 15

Advanced Accelerator Acquires Rights To Fabovar From Dompe 15

Acquisition 16

Dompe Acquires Remaining 51% Stake In Anabasis 16

Biogen Idec Acquires Remaining JV Stake In Biogen Dompe From Dompe 17

Dompe Farmaceutici Acquires 49% Stake In Anabasis, BioPharma Company 18

Dompe Farmaceutici SpA-Key Competitors 19

Key Employees 20

Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Key Facts 1

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Dompe Farmaceutici SpA, Deals By Therapy Area, 2011 to YTD 2017 8

Dompe Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Advanced Accelerator Secures USD57 Million In Venture Financing 10

Lubris Biopharma Enters into Agreement with Dompe Farmaceutici 11

Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 11

Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 12

Scil Proteins Enters Into Licensing Agreement With Anabasis 13

Dompe Enters Into Licensing Agreement With Anabasis 14

Advanced Accelerator Acquires Rights To Fabovar From Dompe 15

Dompe Acquires Remaining 51% Stake In Anabasis 16

Biogen Idec Acquires Remaining JV Stake In Biogen Dompe From Dompe 17

Dompe Farmaceutici Acquires 49% Stake In Anabasis, BioPharma Company 18

Dompe Farmaceutici SpA, Key Competitors 19

Dompe Farmaceutici SpA, Key Employees 20

Dompe Farmaceutici SpA, Other Locations 21

Dompe Farmaceutici SpA, Subsidiaries 21

To know more information on Purchase by Section, please send a mail to

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.